TIS tissue therapies limited

eu trial update

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    I e-mailed Dr. Mercer and asked if there was any known reason why trial results would not be known at the end of June as indicated.

    The important points of his response are these:
    The trial is fully recruited;
    Informal feedback indicates it is proceeding well;
    Professor Harding recently committed to reporting at the end of June;
    There is the possibility that this timeline may be delayed due to Professor Harding's very busy schedule and travel.

    All pretty positive from my perspective!

    Rev
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.